According to a report by iData Research, the US anesthesia, respiratory, and sleep-management device market will reach approximately $4 billion by 2019, with strong growth being driven by the sleep therapy devices market. This market accounts for just over a third of the overall market and includes PAP therapeutic machines and sleep therapy interfaces.
The sleep therapy market will be driven by the growing awareness among the general population of both the symptoms of sleep apnea and the potential dangers associated with leaving the condition untreated. “It is estimated that 70% to 85% of patients that are diagnosed with sleep apnea are recommended some form of [PAP] treatment,” says Dr Kamran Zamanian, CEO of iData, in a release.
Within the sleep therapy industry, low patient compliance to traditional techniques has been the most significant driver of new research and development. Companies have been quick to introduce new features, such as new designs, gel or silicone cushions, or customized fittings meant to address individual patient needs and increase the comfort of the patient while using a PAP device, the report states.